Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsReporting bias in medical research - a narrative reviewUse of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studiesThe imperative to share clinical study reports: recommendations from the Tamiflu experienceHomeopathic Oscillococcinum ® for preventing and treating influenza and influenza-like illnessHomeopathic Oscillococcinum ® for preventing and treating influenza and influenza-like illnessNeuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenNeuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reportsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsZanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsOseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsModeling human influenza infection in the laboratoryEffects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trialEfficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialImpact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling studyThe Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine ModelIota-carrageenan is a potent inhibitor of influenza A virus infectionEffectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in ChinaCan antiviral drugs contain pandemic influenza transmission?We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century.Low clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La RéunionImpact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analysesDifferential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in GermanyTrends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Distinct differences in clinical manifestation and viral laboratory parameters between children and adults with influenza A(H1N1)pdm09 infection--a retrospective comparative analysis.Risk management of seasonal influenza during pregnancy: current perspectives.Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts.Why do we need systematic reviews to inform healthcare decisions in the disaster context.Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan.Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea.French experience of 2009 A/H1N1v influenza in pregnant women.Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission.Preventing and treating secondary bacterial infections with antiviral agentsEmergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic.Vaccination of health-care workers against influenza: our obligation to protect patients.
P2860
Q21090775-1345F8BA-5E61-420E-8D0A-C4711FFEB836Q21203744-22FA6277-CDE1-4DF5-ABC5-46E26BCD9256Q21559446-6A8E5BE4-8C2F-4C89-AEC6-636CCF7838FFQ21563018-F375443B-98D0-4372-AB0F-84EF1736B8B6Q24186485-09F7E17C-39C6-4927-81E6-F6C72E18A2A0Q24202549-DCF6829F-9C5D-40D2-BC82-F37EE0125420Q24203905-D5CB202B-3A54-4CFC-9D0D-6C6CEA11B5D8Q24235164-98B83258-DA7F-4FE3-93D7-3A4AE4248C93Q24240097-9CDA465A-8AD1-4C8C-9751-449D173D54B3Q24244898-37384807-E096-4AAF-9DFA-7597F7774D0EQ24568340-15117568-C008-4EBF-B537-C8BA831AAB9FQ24568345-5F2B4650-DBF4-4B3E-9F84-305056DEE9F2Q26781842-DBB4B60D-3AA1-4320-96CB-76FE6503E049Q28305841-D894BCA5-69B1-4A04-966A-29CDE3797DF3Q28475986-B8F9D2D1-EFA8-446C-9AEA-5D0B75E8A28EQ28537982-FC24B1ED-FFE9-4708-8608-06C719D24384Q28547982-07768C45-F084-4F17-884B-1016DC5E194FQ28744254-DCCAB999-9B18-46C3-896E-7EBDEEAD6D16Q28749090-20A25E3D-0B96-4AE3-8025-88FBA5883E3FQ30226617-5C46BBF9-AAC5-4CCB-849A-96E8E9DF6790Q30226747-5275F661-B7EC-4050-890E-E2182D322CE2Q30227122-9B6F1D04-D104-4D72-ADAB-DF8EB8DE471CQ30235881-E05C612C-F3FD-4BEB-B0A1-C099F24E47C9Q30352949-D8854394-A737-4AEF-AD3B-38242CCF0CB8Q30357688-54D5044E-089E-459E-8CFA-D76D4BD68A5FQ30360059-44B7D7C7-AD59-47E1-A9D1-427EE62D535EQ30365596-93508617-0340-4B86-AFE4-8C739FA375DDQ30368552-86632D51-6BAE-441A-B0B9-0B86080882B6Q30374505-F1A18B5F-0FE0-4A5F-8D05-09F107DF289AQ30384011-3557A301-6A61-40A4-AE0D-B45FA4CE8894Q30387832-9A2B8F64-DA25-4425-AE28-3D5280218F29Q30390834-36FA1F4F-C198-44F3-B053-E3EBA44F5A34Q30391963-5876DC53-E53C-49F1-B9CD-1B4B62671D2DQ30394187-EED226D6-4924-4C5F-A5B3-726A12103768Q30394593-15EE0C51-7B25-4E51-AD89-F367500CF959Q30395018-97AC0CBF-AB7A-4EA1-B127-15865F28D394Q30396017-176A8F75-19F6-4264-A326-0557F67C3E48Q30401260-B1ED3AA1-2E1B-4668-8456-30F8E17163FAQ30402433-0557C75C-C05E-4481-9B6A-AB8600784F8BQ30403785-57344EC5-58A5-4234-8ED1-4593818364FB
P2860
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@ast
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@en
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@nl
type
label
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@ast
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@en
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@nl
prefLabel
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@ast
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@en
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@nl
P2860
P31
P921
P3181
P356
P1433
P1476
Neuraminidase inhibitors for p ...... matic review and meta-analysis
@en
P2093
Peter Doshi
Tom Jefferson
P2860
P3181
P356
10.1136/BMJ.B5106
P407
P433
P5008
P577
2009-12-08T00:00:00Z